Protein Levels and Activity of Some Antioxidant Enzymes in Hippocampus of Subjects with Amnestic Mild Cognitive Impairment

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neurochemical Research

• Publication date

  2008-03-06

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1007/s11064-008-9593-0PMID 18320305
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.

  2007cited by this paper
• Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment

  2007cited by this paper
• [What is a mild cognitive impairment?].

  2007cited by this paper
• Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study

  2007cited by this paper
• Natural antioxidants in Alzheimer's disease

  2007cited by this paper
• Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.

  2007cited by this paper
• Glutathione elevation by γ‐glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implication for chemobrain

  2007cited by this paper
• Mild cognitive impairment

  2006cited by this paper
• Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment

  2006cited by this paper
• Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment.

  2006cited by this paper
• Sources and Targets of Reactive Oxygen Species in Synaptic Plasticity and Memory

  2006cited by this paper
• Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.

  2006cited by this paper
• Nitrosative Stress, Cellular Stress Response, and Thiol Homeostasis in Patients with Alzheimer's Disease

  2006cited by this paper
• Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.

  2006cited by this paper
• Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach.

  2006cited by this paper
• Evidence of increased oxidative damage in subjects with mild cognitive impairment

  2005cited by this paper
• Oxidatively Modified GST and MRP1 in Alzheimer’s Disease Brain: Implications for Accumulation of Reactive Lipid Peroxidation Products

  2004cited by this paper
• Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer’s disease brain

  2004cited by this paper
• Mild cognitive impairment as a diagnostic entity

  2004cited by this paper
• [At the boundary between normal aging and Alzheimer disease].

  2004cited by this paper
• Aux frontières de l’Alzheimer

  2004cited by this paper
• The importance of glutathione in human disease.

  2003cited by this paper
• Proteomic identification of nitrated proteins in Alzheimer's disease brain

  2003cited by this paper
• Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease.

  2003cited by this paper
• Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

  2002cited by this paper
• Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase‐related protein 2, α‐enolase and heat shock cognate 71

  2002cited by this paper
• Nutritional approaches to combat oxidative stress in Alzheimer's disease.

  2002cited by this paper
• Superoxide dismutase--applications and relevance to human diseases.

  2002cited by this paper
• Role of superoxide dismutases in oxidative damage and neurodegenerative disorders.

  2002cited by this paper
• Book Review: Role of Superoxide Dismutases in Oxidative Damage and Neurodegenerative Disorders

  2002cited by this paper
• Mild cognitive impairment: transition between aging and Alzheimer's disease.

  2000cited by this paper
• Efficacy and Safety of OK-432 Sclerotherapy for Giant Cystic Hygroma in a Newborn

  2000cited by this paper
• The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease

  1999cited by this paper
• Glutathione and its role in cellular functions.

  1999cited by this paper
• ATP‐ and glutathione‐dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1

  1999cited by this paper
• Glutathione Therapy: From Prodrugs to Genes

  1998cited by this paper
• Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease

  1998cited by this paper
• Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death.

  1997cited by this paper
• Multiple roles of glutathione in the central nervous system.

  1997cited by this paper
• Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system.

  1995cited by this paper
• Oxygen radicals as key mediators in neurological disease: Fact or fiction?

  1992cited by this paper
• Reactive Oxygen Species and the Central Nervous System

  1992cited by this paper
• Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.

  1991cited by this paper
• Glutathione reductase.

  1985cited by this paper
• [59] Glutathione reductase

  1985cited by this paper
• Glutathione.

  1983cited by this paper
• Assays for differentiation of glutathione S-transferases.

  1981cited by this paper

• Protective effects of alpha-lipoic acid on memory deficit induced by repeated doses of solifenacin in mice: the role of nitro-oxidative stress

  2025influential citation
• The Missing Link in Antiamyloid Therapy.

  2025cites this paper
• A review on Centella asiatica (L.) nutrient and phytochemical composition and its potential neuroprotective effect in Alzheimer’s disease

  2025cites this paper
• Protective role of fucoidan against cognitive deficits and redox imbalance in a scopolamine-induced Alzheimer’s disease model in rats

  2025cites this paper
• MRS demonstrates elevated brain glutathione in vascular mild cognitive impairment compared to cognitively normal coronary artery disease controls

  2025cites this paper
• Longitudinal Monitoring of Glutathione Stability in Different Microenvironments

  2024cites this paper
• Between-networks hyperconnectivity is induced by beta-amyloid and may facilitate tau spread

  2024cites this paper
• Crosstalk between Oxidative Stress and Inflammation Caused by Noise and Air Pollution—Implications for Neurodegenerative Diseases

  2024cites this paper
• Quantitation of Brain and Blood Glutathione and Iron in Healthy Age Groups Using Biophysical and In Vivo MR Spectroscopy: Potential Clinical Application.

  2023cites this paper
• Moschus exerted protective activity against H2O2-induced cell injury in PC12 cells through regulating Nrf-2/ARE signaling pathways.

  2023cites this paper
• Distribution Pattern of Closed and Extended Forms of Glutathione in the Human Brain: MR Spectroscopic Study.

  2023cites this paper
• Blood Biomarkers in Alzheimer’s Disease

  2023cites this paper
• Oxidative Stress Occurs Prior to Amyloid Aβ Plaque Formation and Tau Phosphorylation in Alzheimer’s Disease: Role of Glutathione and Metal Ions

  2023cites this paper
• In vivo study of dose-dependent antioxidant efficacy of functionalized core–shell yttrium oxide nanoparticles

  2022cites this paper
• Hippocampal glutathione depletion with enhanced iron level in patients with mild cognitive impairment and Alzheimer’s disease compared with healthy elderly participants

  2022cites this paper
• Oxidative Stress: Glutathione and Its Potential to Protect Methionine-35 of Aβ Peptide from Oxidation

  2022cites this paper
• Vascular and Nonvascular Mechanisms of Cognitive Impairment and Dementia.

  2022cites this paper
• Interplay Between Hippocampal Glutathione Depletion and pH Increment in Alzheimer’s Disease

  2022cites this paper
• Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer’s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside

  2021cites this paper
• Mitochondrial dysfunction and autophagy in neurodegeneration

  2021cites this paper
• In Vivo Brain GSH: MRS Methods and Clinical Applications

  2021cites this paper
• Nutraceutical and therapeutic potential of Phycocyanobilin for treating Alzheimer’s disease

  2021cites this paper
• Ginseng: A Boon or a Curse to Neurodegenerative Diseases

  2021cites this paper
• A New Insight into an Alternative Therapeutic Approach to Restore Redox Homeostasis and Functional Mitochondria in Neurodegenerative Diseases

  2021cites this paper
• Hippocampal Glutathione Depletion and pH Increment in Alzheimer’s Disease: An in vivo MRS Study

  2021cites this paper
• Mitochondria and cellular redox state on the route from ageing to Alzheimer's disease.

  2020cites this paper
• Comparative Effects of Alpha- and Gamma-Tocopherol on Mitochondrial Functions in Alzheimer’s Disease In Vitro Model

  2020cites this paper
• Neurodegenerative Diseases: Potential Effect of Glutathione

  2020cites this paper
• Glutathione in Brain: Overview of Its Conformations, Functions, Biochemical Characteristics, Quantitation and Potential Therapeutic Role in Brain Disorders

  2020cites this paper
• Disorders of glutathione metabolism

  2020cites this paper
• [Plasmatic glutathione levels and their relationships with clinical and therapeutic features in patients with schizophrenia].

  2020cites this paper
• Metabolic Dysregulation Contributes to the Progression of Alzheimer’s Disease

  2020cites this paper
• ANSH: Multimodal Neuroimaging Database Including MR Spectroscopic Data From Each Continent to Advance Alzheimer’s Disease Research

  2020cites this paper
• Effects of Oxytocin Administration on Oxidative Markers in the Temporal Lobe of Aged Rats

  2019cites this paper
• Oxidative Stress: A Key Modulator in Neurodegenerative Diseases

  2019cites this paper
• Diffusion tensor imaging based white matter changes and antioxidant enzymes status for early identification of mild cognitive impairment

  2019cites this paper
• Effects of Oxytocin Administration on Oxidative Markers in the Temporal Lobe of Aged Rats

  2019cites this paper
• Identification d'un profil de marqueurs périphériques lié aux scores cognitifs dans le plasma et les vésicules extracellulaires durant le développement de la maladie d'Alzheimer: évolution de marqueurs liés au stress oxydatif et aux mécanismes physiopathologiques.

  2019cites this paper
• Salivary Redox Biomarkers in Different Stages of Dementia Severity

  2019cites this paper
• Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View

  2019cites this paper
• Early compensatory responses against neuronal injury: A new therapeutic window of opportunity for Alzheimer's Disease?

  2018cites this paper
• Beneficial effects of white wine polyphenols-enriched diet on Alzheimer's disease-like pathology.

  2018cites this paper
• Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies

  2018cites this paper
• Protective role of rosmarinic acid on amyloid beta 42‐induced echoic memory decline: Implication of oxidative stress and cholinergic impairment

  2018influential citation
• Markers of oxidative damage to lipids, nucleic acids and proteins and antioxidant enzymes activities in Alzheimer's disease brain: A meta‐analysis in human pathological specimens

  2018cites this paper
• Tocotrienol-Rich Fraction of Palm Oil Improves Behavioral Impairments and Regulates Metabolic Pathways in AβPP/PS1 Mice

  2018cites this paper
• The interaction of pollution, meteorology and bioaerosols : implications on human health

  2018cites this paper
• The effect of N‐acetylcysteine (NAC) on human cognition – A systematic review

  2017cites this paper
• Lipid Peroxidation Markers in Coronary Artery Disease Patients with Possible Vascular Mild Cognitive Impairment

  2017cites this paper
• Energy and the Alzheimer brain

  2017cites this paper
• From redox proteomics to clinical practice : search for therapeutic targets

  2017cites this paper
• Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases

  2017cites this paper
• LOWER POSTERIOR CINGULATE CORTEX GLUTATHIONE LEVELS IN OBSESSIVE-COMPULSIVE DISORDER.

  2016cites this paper
• Reduction of Oxidative/Nitrosative Stress in Brain and its Involvement in the Neuroprotective Effect of n-3 PUFA in Alzheimer's Disease.

  2016cites this paper
• Editorial: Oxidative Stress and Alzheimer Disease: Where Do We Stand?

  2016cites this paper
• Measurement of nitric oxide metabolites and protein nitration in healthy and inflammatory human tissues and bio-fluids

  2016cites this paper
• Effects of APOE rs429358, rs7412 and GSTM1/GSTT1 Polymorphism on Plasma and Erythrocyte Antioxidant Parameters and Cognition in Old Chinese Adults

  2015cites this paper
• Transcriptomic Analysis of Drosophila Mushroom Body Neurons Lacking Amyloid-β Precursor-Like Protein Activity

  2015cites this paper
• Glutathione in Cellular Redox Homeostasis: Association with the Excitatory Amino Acid Carrier 1 (EAAC1)

  2015cites this paper
• Effects of acupuncture at HT7 on glucose metabolism in a rat model of Alzheimer's disease: an 18F-FDG-PET study

  2015cites this paper
• Circulating Oxidative Damage and Antioxidant Defense System Biomarkers in Early Stage Alzheimer’s Disease

  2015cites this paper
• Oxidative Stress in Neurodegenerative Diseases

  2015cites this paper
• The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.

  2014cites this paper
• Análisis del papel protector de los polifenoles en enfermedades neurodegenerativas

  2014cites this paper
• Estrés Oxidativo y Esquizofrenia

  2014cites this paper
• Oxidative Stress in Alzheimer's Disease: Why Did Antioxidant Therapy Fail?

  2014cites this paper
• The Emerging Role of Glutathione in Alzheimer's Disease

  2014cites this paper
• Rat hippocampal responses up to 90 days after a single nanoceria dose extends a hierarchical oxidative stress model for nanoparticle toxicity

  2014influential citation
• The 2013 Discovery Award from the Society for Free Radical Biology and Medicine : Selected Discoveries from the Butterfield Laboratory of Oxidative Stress and Its Sequelae in Brain in Cognitive Disorders Exemplified by Alzheimer Disease and Chemotherapy Induced Cognitive Impairment

  2014cites this paper
• Glutathione relates to neuropsychological functioning in mild cognitive impairment

  2014cites this paper
• The Potential of Cerebrolysin in the Treatment of Schizophrenia

  2014cites this paper
• Antioxidative effects of the methanolic extract of Hibiscus asper leaves in mice

  2014cites this paper
• Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment

  2013cites this paper
• ASSESSMENT OF PATHOPHYSIOLOGICAL MECHANISMS IN ETIOPATHOGENY OF CHRONIC AND AGGRESSIVE PERIODONTAL DISEASE DOCTORATE THESIS - Abstract -

  2013cites this paper
• Diet, Nutritional Status, Inflammation and Functional Outcomes in Older Adults Residing in Long Term Care Homes

  2013cites this paper
• Molecular changes during the development of Alzheimer's disease

  2013cites this paper
• Mixed ligand Cu2+ complexes of a model therapeutic with Alzheimer's amyloid-β peptide and monoamine neurotransmitters.

  2013cites this paper
• Reactive Oxygen species: The main culprit of Alzheimer Disease.

  2013cites this paper
• Early Molecular Changes in Alzheimer Disease: Can We Catch the Disease in its Presymptomatic Phase?

  2013cites this paper
• Chapter 7 Insights from Proteomics into Mild Cognitive Impairment , Likely the Earliest Stage of Alzheimer ' s Disease

  2013cites this paper
• 6-hydroxy-l-nicotine from Arthrobacter nicotinovorans sustain spatial memory formation by decreasing brain oxidative stress in rats

  2013cites this paper
• Oxidative Stress in Alzheimer's Disease and Mild Cognitive Impairment with High Sensitivity and Specificity

  2013cites this paper
• Amyloid β-Peptide (1–42)-Induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression

  2013cites this paper
• Impaired Glutathione Synthesis in Neurodegeneration

  2013cites this paper
• Molecular changes during the development of Alzheimer's disease General introduction Early molecular changes in Alzheimer Disease - can we catch the disease in its presymptomatic phase? 1 that

  2013cites this paper
• Oxidative modification of lipoic acid by HNE in Alzheimer disease brain

  2013cites this paper
• The neurotoxicity of β-amyloid peptide toward rat brain is associated with enhanced oxidative stress, inflammation and apoptosis, all of which can be attenuated by scutellarin.

  2013cites this paper
• The neuropathological profile of mild cognitive impairment (MCI): a systematic review

  2012cites this paper
• Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia.

  2012cites this paper
• Mitochondrial- and Endoplasmic Reticulum-Associated Oxidative Stress in Alzheimer's Disease: From Pathogenesis to Biomarkers

  2012cites this paper
• Chapter 32 SAMP 8 : A model to understand the role of oxidative stress in age-related diseases including Alzheimer ’ s disease

  2012cites this paper
• Elevation of glutathione as a therapeutic strategy in Alzheimer disease.

  2012cites this paper
• Elevated Oxidative Stress and Decreased Antioxidant Function in the Human Hippocampus and Frontal Cortex with Increasing Age: Implications for Neurodegeneration in Alzheimer’s Disease

  2012cites this paper
• Rat brain pro-oxidant effects of peripherally administered 5 nm ceria 30 days after exposure.

  2012cites this paper
• Sporadic Alzheimer's Disease: The Starving Brain

  2012cites this paper
• Redox Proteomics Analysis of Brains from Subjects with Amnestic Mild Cognitive Impairment Compared to Brains from Subjects with Preclinical Alzheimer's Disease: Insights into Memory Loss in MCI

  2011cites this paper
• Protein Modification by Dicarbonyl Molecular Species in Neurodegenerative Diseases

  2011cites this paper
• Acute and chronic effects of electroconvulsive treatment on oxidative parameters in schizophrenia patients.

  2011cites this paper
• Nutritional approaches to modulate oxidative stress in Alzheimer's disease.

  2011cites this paper
• Oxidative stress in schizophrenia - focusing on the main markers.

  2011cites this paper